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Fine-needleaspirationbiopsyisregardedasanimportanttoolfordiagnosingthyroidlesions
because of its simplicity, safety, and cost–effectiveness. Its role in correctly characterizing
the group of indeterminate lesions or follicular-patterned neoplasms (FN) might be more
decisive. Liquid-based cytology (LBC) is a technique based on the use of a semi-automated
devicethathasgainedpopularityasamethodofcollectingandprocessingbothgynecologic
and non-gynecologic cytologic specimens. It achieves a diagnostic sensitivity as accurate
as conventional preparations especially for its excellent cell preservation and for the lack of
background which decrease the amount of inadequate diagnoses. Moreover, the cellular
material which has been stored in the preservative solution could be effectively used for
the application of immunocytochemical and molecular techniques especially for the Follic-
ular proliferations. In many cases the cytologic features are similar in both methods but the
colloid ﬁlm and the lymphocytic component are more easily evaluated on direct smears
whereas nuclear details and colloid globules are better evaluated in LBC slides.The LBC-
processed biopsies represent a valid alternative to conventional cytology. The possibility
of applying special techniques enhance the efﬁcacy of the cytological diagnosis of thyroid
lesions.
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INTRODUCTION
Fine-needle aspiration biopsy (FNAB) represents an invaluable
diagnostic tool for characterizing thyroid nodules with a world-
wide consensus for its simplicity, safety (Galera-Davidson and
Gonzalez-Campora,2008),andregardedasthemostaccurateand
cost–effective method for the selection of surgical patients.
The liquid-based cytology (LBC) technique, originally devel-
oped for application to gynecologic cervical smears, has progres-
sively gained consensus for both non-gynecologic and ﬁne-needle
aspiration cytological material (Biscotti et al., 1995; Rossi and
Fadda, 2008; Rossi et al., 2009).
This method is based on a two-step procedure: (1) the ﬁxation
of the material in an methanol-based solution and (2) the auto-
mated processing of the material to obtain a thin layer of cells
with a computer-assisted device. The two most common methods
forprocessingthecytologicsamplesare:ThinPrep2000™(Hologic
Co., Marlborough, MA, USA), in which the cells are aspirated
from a methanol-based solution (Cytolyt™) then ﬁltered and
transferred onto a positively charged slide with a gentle positive
pressure; in the method SurePath™(TriPath Imaging, Burlington,
NC, USA) the cells are collected in an ethanol-based solution
(CytoRich™), centrifuged twice then slowly sedimentated onto
a poly-l-lysinated slide and eventually stained with a speciﬁc
hematoxylin–eosin stain. The ﬁnal result for both methods is one
slideforeachlesionwithallcellsconcentratedinthecentralareaof
the slide with a sensitivity of 77% and a speciﬁcity of 81% (Geers
and Bourgain,2011).
Despite the initial controversy regarding the efﬁcacy of the use
of Thin Prep alone (Cochand-Priollet et al., 2003; Fadda et al.,
2006; Rossi et al., 2010) good results have been achieved by many
groups in different countries, especially in the recent years. Since
November 2003 until 2011 the majority of about 22,000 FNABs
carriedoutinthe“AgostinoGemelli”SchoolofMedicineandHos-
pital of Rome have been processed by ThinPrep2000™alone. This
experiencehasbeenreportedinmanystudiespublishedsince2005
where the efﬁcacy of the ThinPrep2000™technique for a correct
pre-operative diagnosis of more than 500 malignant neoplasms is
highlighted.InthestudybyRossietal.(2009),threeparametersof
efﬁcacy (inadequacy, indeterminacy, and malignancy rates) were
chosen for evaluating the efﬁcacy of ThinPrep2000™in compari-
sonwithCSaloneandcombiningThinPrep2000™andCSinmore
than10,000thyroidFNABshowingthatThinPrep2000™alonewas
aseffectiveasCSindecreasingbothinadequateandindeterminate
diagnoses (Fadda et al., 2011b). The study of Geers and Bourgain
(2011) using the SurePath method achieves controversial results
in terms of inadequacy rate between LBC and SurePath.
The ThinPrep2000™material stored in the vial can be used for
additionaltechniquessuchasimmunocytochemistry,ﬂowcytom-
etry, and molecular biology (Cochand-Priollet et al., 2003; Rossi
et al.,2005).
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CYTOLOGY OF LBC-PROCESSED THYROID LESIONS
BENIGN LESIONS
The morphologic picture of LBC differs mainly from CS in two
aspects:(a)thecellsineachslideareamonolayeredrepresentative
sample of the entire material collected in the vial with a vari-
able amount of cells which remains in the preservative solution;
(b) the automated process causes some changes in both cellular
and background morphology. One of the most important change,
occurring in LBC slides, is the appearance of the fragmented col-
loid which is present as small droplets in the background of a
benign nodule with a quantitative detection whereas in CS the
colloid usually does not require a quantization (Figure 1; Biscotti
et al., 1995). The LBC picture of a thyroiditis is similar to CS
with the exception of the amount of lymphocytes in the back-
ground which can be higher than normal because of the spinning
of the material before the automated process. When a thyroidi-
tis is suspected, the detection of lympho-epithelial clusters in an
inﬂammatorybackgroundisthepivotalclueforthediagnosisand
warrants a simple follow-up for the patient (Das, 2006).
FOLLICULAR-PATTERNED LESIONS
Thereareveryfewdifferencesinthecytologicpicturesof follicular
neoplasms (FN) in LBC versus CS based upon the identiﬁcation
of microfollicles made up of medium-sized thyrocytes in scant
colloid. The amount and morphology of the follicular cells allow
the inclusion of an individual lesion in one of the categories that
have been recently devised in Europe and in the USA with three
possible scenario (British ThyroidAssociation,2007;Baloch et al.,
2008; Fadda et al.,2010):
(1) The ﬁrst scenario is represented by a lesion which high cel-
lularity but the cells are monomorphous with occasional
enlarged nuclei. This lesion may correspond to the cellular
adenomatous nodule and is usually included in the non-
neoplastic category of the European classiﬁcations (Thy 2 by
FIGURE 1 |A case of colloid goiter exhibiting small clusters of
monomorphic follicular cells mixed with colloid droplets (LBC,
Papanicolaou, 400×).
BTA classiﬁcation, TIR 2 by Italian classiﬁcation,). On the
other hand, the Bethesda classiﬁcation has established a dif-
ferent category for this picture which is deﬁned as “follicular
lesion with undetermined signiﬁcance (FLUS)” or “atypical
cells of undetermined signiﬁcance (ACUS or AUS)” with a
different risk of malignant occurrence which in theAmerican
classiﬁcation is stated between 5 and 15% (mostly follicular
carcinoma) whereas in the European systems is closer to non-
neoplastic lesions (British Thyroid Association, 2007; Baloch
et al.,2008; Fadda et al.,2010).
(2) The second scenario is represented by a lesion mostly
follicular-structured and made up of medium-sized thyro-
cytes with rounded nuclei and central nucleolus (Follicular
Neoplasm) with a malignancy risk between 20 and 30%.
The action, although debated in the literature, results in the
surgicalremovalofthelesionwhichcouldhistologicallycorre-
spondtobothafollicularadenomaoranadenomatousnodule
in a goiter (70–80% of cases) but also follicular carcinoma or
a follicular variant of a papillary carcinoma (PC) cannot be
ruled out only on morphology. The same diagnostic criteria
and therapeutic action is applied to the FN composed mostly
by oxyphilic (or Hurthle) cells which is deﬁned when follicles
aremadeupof morethan80%of oxyphiliccellsanditshould
be included in the FN category (Thy 3 of the BTA, TIR 3 of
the Italian classiﬁcations). The colloid amount may be scant
(but sometimes is abundant) and features of old hemorrhage
(hemosiderin-ladenhistiocytes)maycoexist(Giorgadzeetal.,
2004; British Thyroid Association,2007; Baloch et al.,2008).
(3) The third scenario is represented by follicular-structured
lesions, composed by thyrocytes with elongated and clear
nuclei,sometimes with grooves and peripheral nucleoli with-
out papillae,psammomatous bodies,or nuclear pseudoinclu-
sions with a risk of malignancy ranging between 50 and 70%.
This category warrants the surgical removal of the nodule as
a follicular variant of a PC is very likely to be found at the
histological examination (more than 90% of cases).
MALIGNANT TUMORS
The cytological diagnosis of thyroid malignancy does not differ
substantially in LBC preparations as the clear background facili-
tates the identiﬁcation and characterization of the cellular details.
The most important malignant tumor which can be appropri-
ately identiﬁed on LBC preparations is PC which is easily when
nuclear pseudoinclusions are detected (Figure 2) papillary struc-
tures and psammoma bodies are seldom identiﬁed. In the earlier
reports,thedifﬁcultyindetectingthedistinctivenuclearfeaturesof
PCwasoneof themostimportantobjectionsagainsttheadoption
of the thyroid LBC cytology.
Medullary thyroid carcinoma (MTC) is a difﬁcult cytological
diagnosis. The LBC technique offers the opportunity to detect the
calcitoninexpressionintheneoplasticparafollicularcellsandtheir
concomitant negativity for thyroglobulin (Rossi et al.,2008).
Anaplastic thyroid carcinoma (ATC) is seldom seen in rou-
tine thyroid cytology. The LBC picture of ATC usually shows a
background of necrotic debris with small clusters of large round
or spindle cells with pleomorphic nuclei and prominent nucleoli
which stains positive for cytokeratins (useful to conﬁrm the
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FIGURE 2 |A distinctive nuclear pseudoinclusion in a ﬁne-needle
aspiration biopsy from a thyroid papillary carcinoma (LBC,
Papanicolau, 400×).
epithelial origin) and negative for thyroglobulin and TTF-1. The
LBC diagnosis of the large cell variant of malignant non-Hodgkin
lymphomausuallydoesnotconstituteaproblemandreliesonthe
immunocytochemical expression of LCA, CD20, bcl-6, and other
lymphoid antigens.
Lung,breast,kidney,large bowel,and laryngeal metastatic car-
cinomas to the thyroid gland may occasionally present as a single
nodule mimicking a primary tumor in which necrotic debris or
hemorrhagicmaterialandclustersof neoplasticcellswithfeatures
of adenocarcinoma or squamous cell carcinoma are detected on
Cs and ThinPrep2000™
SPECIAL TECHNIQUES
IMMUNOCYTOCHEMISTRY
Immunocytochemistry was introduced in the early 1970s for the
deﬁnition of the nature of the lesions,especially in the differential
diagnosis between follicular and C-cell derived neoplasms and in
theidentiﬁcationofprimaryormetastaticthyroidneoplasms(e.g.,
malignantlymphoma)evenif themainroleistheidentiﬁcationof
themarkersof malignancywhichmaydistinguishmalignantfrom
benign lesions regardless of the presence of capsular and vascular
invasion (Rossi et al.,2006).
T h e r eh a v eb e e no n l yf e wr e p o r t e de x p e r i e n c e si nl i t e r a t u r e
dealing with ICC applied on ThinPrep2000™. The use of ICC on
the cells stored in the preservative ThinPrep2000™solution yields
excellent results with most immunoreagents in terms of staining
pattern,intensityof thereactionandlessamountof reagentdueto
the clear background and smaller size of the ThinPrep2000™slide
(Dabbs et al.,1997; Leung and Bedard,1999; Rossi et al.,2006).
Inourpracticeandbasedonthedataintheliterature,no“magic
single marker”may be useful but only the concordance of a panel
should be considered especially in cases of follicular lesions. The
use of more than one immunomarker is a further guarantee for a
correct diagnostic approach, especially when a concordant panel
is expressed (Rossi et al., 2006) and with excellent results also in
the differential diagnosis between benign and malignant follicular
neoplasms (Dabbs et al., 1997; Leung and Bedard, 1999; Schmitt
et al.,2008; Fadda et al.,2011a).
HBME-1, Galectin-3, and RET proto-oncogene have shown
the best speciﬁcity and sensitivity in discriminating benign from
malignant differentiated tumors. These data emerged from one
of the paper of our group, in which the combination of nuclear
pleomorphism and positivity of the panel resulted in 75% speci-
ﬁcity and 89% diagnostic accuracy of FNAB (Rossi et al., 2005).
In another study recently published by our group, the complete
immunocytochemical panel (made up of HBME-1 and Galectin-
3) was positive in 83.3% of malignancy and negative in 87.5%
benign histological cases. In the group of FN/AUS (according to
the Bethesda system), the expression of HBME-1 and Galectin-3
on LBC can effectively distinguish lesions which need immediate
surgery (high risk FN) from those which can be followed-up (low
risk FN).
MOLECULAR TECHNIQUES
Recent advances in molecular genetics of thyroid cancer are being
appliedfordevelopingnewdiagnosticmarkersforFNAsamplesin
anattempttodifferentiatebenignfrommalignantthyroidnodules
(Nikiforova and Nikiforov, 2009). PC, the most common thyroid
malignancy, may carry BRAF, Ret/PTC, or RAS mutations (Niki-
forova and Nikiforov, 2009). These mutually exclusive somatic
mutationsarefoundinmorethan70%of PCswithamoreaggres-
sive tumor behavior such as extra-thyroidal extension, advanced
tumor stage at presentation and lymph node or distant metastases
(Xing, 2007).
Several studies have demonstrated the feasibility of detecting
BRAF, RET/PTC, or RAS mutation in thyroid FNA samples and
have shown that this may improve the cytological FNA diagnosis
(Nikiforova and Nikiforov, 2009; Ohori et al., 2010; Fadda et al.,
2011b).
A recent paper by Nikiforova and Nikiforov (2009) explored
the diagnostic utility of molecular testing for a panel of molecular
mutationsconsistingonBRAF,RAS,RET/PTC,andPAX8–PPARγ
in 480 FNA samples from thyroid nodules which were prospec-
tively tested and yielded 32 mutations with 31 malignant surgical
diagnoses and only one case of follicular adenoma.
Thepossiblediagnosticuseof molecularmarkersisreﬂectedin
thelastguidelinespublishedbytheAmericanThyroidAssociation.
These guidelines indicate that the use of molecular markers such
as BRAF, RAS, RET/PTC, and PAX8–PPARγ may be considered
(with low recommendation rate) for patients with indeterminate
FNA cytology to help guide their clinical management.
As resulted in our preliminary study the evaluation of BRAF
positivity could be a prognostic value for the presence of nodal
metastases and the presence of BRAF positivity performances to
thesurgicalneckcentraldissectionandalsotothedetectionof any
other nodal possible implication (Fadda et al.,2011b).
Liquid-basedcytologycanofferthepossibilityofimmunocyto-
chemical evaluation and molecular testings for common somatic
mutations in thyroid FNAB as the nucleic acids are stable in the
preservative solution up to 6months after the sampling. In this
setting, the future possibility of a guideline encompassing the
combined use of immunocytochemistry and molecular tests for
supplementing the morphologic diagnosis could be the starting
point for a complete pre-operative assessment of a thyroid lesion.
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